{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:06:49Z","timestamp":1790381209646,"version":"4.1.0"},"reference-count":46,"publisher":"Baishideng Publishing Group Inc.","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.2731","type":"journal-article","created":{"date-parts":[[2008,5,20]],"date-time":"2008-05-20T00:57:21Z","timestamp":1211245041000},"page":"2731","source":"Crossref","is-referenced-by-count":54,"title":["Mitochondrial protection by low doses of insulin-like growth factor-Iin experimental cirrhosis"],"prefix":"10.3748","volume":"14","author":[{"given":"Raquel","family":"P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Garc\u00eda-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"D\u00edaz-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan E","family":"Puche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Conchillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Muntan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inma","family":"Castilla-Cort\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 1990;70:591-614.","DOI":"10.1152\/physrev.1990.70.3.591"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Caufriez A, Reding P, Urbain D, Golstein J, Copinschi G. Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. J Endocrinol Invest 1991;14:317-321.","DOI":"10.1007\/BF03346823"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Hattori N, Kurahachi H, Ikekubo K, Ishihara T, Moridera K, Hino M, Saiki Y, Imura H. Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis. Metabolism 1992;41:377-381.","DOI":"10.1016\/0026-0495(92)90071-H"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Picardi A, de Oliveira AC, Muguerza B, Tosar A, Quiroga J, Castilla-Cortazar I, Santidrian S, Prieto J. Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol 1997;26:191-202.","DOI":"10.1016\/S0168-8278(97)80026-8"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Castilla-Cortazar I, Prieto J, Urdaneta E, Pascual M, Nunez M, Zudaire E, Garcia M, Quiroga J, Santidrian S. Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I. Gastroenterology 1997;113:1180-1187.","DOI":"10.1053\/gast.1997.v113.pm9322513"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Castilla-Cortazar I, Picardi A, Tosar A, Ainzua J, Urdaneta E, Garcia M, Pascual M, Quiroga J, Prieto J. Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats. Am J Physiol 1999;276:G37-G42.","DOI":"10.1152\/ajpgi.1999.276.1.G37"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Castilla-Cortazar I, Garcia M, Quiroga J, Diez N, Diez-Caballero F, Calvo A, Diaz M, Prieto J. Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis. Hepatology 2000;31:592-600.","DOI":"10.1002\/hep.510310308"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Pascual M, Castilla-Cortazar I, Urdaneta E, Quiroga J, Garcia M, Picardi A, Prieto J. Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I. Am J Physiol Gastrointest Liver Physiol 2000;279:G319-G324.","DOI":"10.1152\/ajpgi.2000.279.2.G319"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Cemborain A, Castilla-Cortazar I, Garcia M, Quiroga J, Muguerza B, Picardi A, Santidrian S, Prieto J. Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol 1998;28:122-131.","DOI":"10.1016\/S0168-8278(98)80211-0"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Cemborain A, Castilla-Cortazar I, Garcia M, Muguerza B, Delgado G, Diaz-Sanchez M, Picardi A. Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis. J Physiol Biochem 2000;56:91-99.","DOI":"10.1007\/BF03179904"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Castilla-Cortazar I, Aliaga-Montilla MA, Salvador J, Garcia M, Delgado G, Gonzalez-Baron S, Quiroga J, Prieto J. Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats. Liver 2001;21:405-409.","DOI":"10.1034\/j.1600-0676.2001.210607.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Castilla-Cortazar I, Garcia M, Muguerza B, Quiroga J, Perez R, Santidrian S, Prieto J. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology 1997;113:1682-1691.","DOI":"10.1053\/gast.1997.v113.pm9352873"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Mirpuri E, Garcia-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, Mato JM, Prieto J, Avila MA. Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int J Biochem Cell Biol 2002;34:242-252.","DOI":"10.1016\/S1357-2725(01)00123-6"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Garcia-Fernandez M, Castilla-Cortazar I, Diaz-Sanchez M, Navarro I, Puche JE, Castilla A, Casares AD, Clavijo E, Gonzalez-Baron S. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. BMC Gastroenterol 2005;5:7.","DOI":"10.1186\/1471-230X-5-7"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Muguerza B, Castilla-Cortazar I, Garcia M, Quiroga J, Santidrian S, Prieto J. Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. Biochim Biophys Acta 2001;1536:185-195.","DOI":"10.1016\/S0925-4439(01)00045-X"},{"key":"ref16","unstructured":"Bailey SM, Cunningham CC. Contribution of mitochondria to oxidative stress associated with alcoholic liver disease. Free Radic Biol Med 2002;32:11-16."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Bailey SM, Pietsch EC, Cunningham CC. Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III. Free Radic Biol Med 1999;27:891-900.","DOI":"10.1016\/S0891-5849(99)00138-0"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Kwong LK, Sohal RS. Age-related changes in activities of mitochondrial electron transport complexes in various tissues of the mouse. Arch Biochem Biophys 2000;373:16-22.","DOI":"10.1006\/abbi.1999.1495"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1999;26:463-471.","DOI":"10.1016\/S0891-5849(98)00216-0"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Cardoso SM, Pereira C, Oliveira R. Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 1999;26:3-13.","DOI":"10.1016\/S0891-5849(98)00205-6"},{"key":"ref21","unstructured":"Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease. Prog Liver Dis 1996;14:131-159."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis 2002;22:137-144.","DOI":"10.1055\/s-2002-30100"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Kiningham KK, Oberley TD, Lin S, Mattingly CA, St Clair DK. Overexpression of manganese superoxide dismutase protects against mitochondrial-initiated poly(ADP-ribose) polymerase-mediated cell death. FASEB J 1999;13:1601-1610.","DOI":"10.1096\/fasebj.13.12.1601"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Cortopassi GA, Wong A. Mitochondria in organismal aging and degeneration. Biochim Biophys Acta 1999;1410:183-193.","DOI":"10.1016\/S0005-2728(98)00166-2"},{"key":"ref25","unstructured":"The Guiding Principles for Research Involving Animals. National Academy of Sciences. The National Institute of Health -NIH 1991;."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.","DOI":"10.1016\/0891-5849(91)90192-6"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464-478.","DOI":"10.1016\/0076-6879(90)86141-H"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"O&rsquo;Connor JE, Vargas JL, Kimler BF, Hernandez-Yago J, Grisolia S. Use of rhodamine 123 to investigate alterations in mitochondrial activity in isolated mouse liver mitochondria. Biochem Biophys Res Commun 1988;151:568-573.","DOI":"10.1016\/0006-291X(88)90632-8"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Hatefi Y, Haavik AG, Griffiths DE. Studies on the electron transfer system. XL. Preparation and properties of mitochondrial DPNH-coenzyme Q reductase. J Biol Chem 1962;237:1676-1680.","DOI":"10.1016\/S0021-9258(19)83761-4"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Trounce I, Byrne E, Dennett X, Chen WW, Marzuki S. Affinity chromatography isolation of human cytochrome oxidase and small-scale Western immunoblot probing of the enzyme complex in mitochondrial cytopathy patients. Biochem Med Metab Biol 1991;46:17-27.","DOI":"10.1016\/0885-4505(91)90046-N"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Hoek JB, Cahill A, Pastorino JG. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology 2002;122:2049-2063.","DOI":"10.1053\/gast.2002.33613"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Sastre J, Serviddio G, Pereda J, Minana JB, Arduini A, Vendemiale G, Poli G, Pallardo FV, Vina J. Mitochondrial function in liver disease. Front Biosci 2007;12:1200-1209.","DOI":"10.2741\/2138"},{"key":"ref33","unstructured":"Jelski W, Chrostek L, Szmitkowski M. [Biochemical basic of alcoholic liver injury]. Pol Merkur Lekarski 2006;21:376-380."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, Bernardi M. Review article: alcoholic liver disease--pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006;24:1151-1161.","DOI":"10.1111\/j.1365-2036.2006.03110.x"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Shukla SD, Aroor AR. Epigenetic effects of ethanol on liver and gastrointestinal injury. World J Gastroenterol 2006;12:5265-5271.","DOI":"10.3748\/wjg.v12.i33.5265"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Cunningham CC, Bailey SM. Ethanol consumption and liver mitochondria function. Biol Signals Recept 2001;10:271-282.","DOI":"10.1159\/000046892"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 2006;65:278-290.","DOI":"10.1079\/PNS2006496"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Krahlenbuhl S, Reichen J, Zimmermann A, Gehr P, Stucki J. Mitochondrial structure and function in CCl4-induced cirrhosis in the rat. Hepatology 1990;12:526-532.","DOI":"10.1002\/hep.1840120313"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Bras M, Queenan B, Susin SA. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc) 2005;70:231-239.","DOI":"10.1007\/s10541-005-0105-4"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003;195:158-167.","DOI":"10.1002\/jcp.10254"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999;68:383-424.","DOI":"10.1146\/annurev.biochem.68.1.383"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Gu Y, Wang C, Cohen A. Effect of IGF-1 on the balance between autophagy of dysfunctional mitochondria and apoptosis. FEBS Lett 2004;577:357-360.","DOI":"10.1016\/j.febslet.2004.10.040"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Leinninger GM, Russell JW, van Golen CM, Berent A, Feldman EL. Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma. Cell Death Differ 2004;11:885-896.","DOI":"10.1038\/sj.cdd.4401429"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Kondo T, Kitano T, Iwai K, Watanabe M, Taguchi Y, Yabu T, Umehara H, Domae N, Uchiyama T, Okazaki T. Control of ceramide-induced apoptosis by IGF-1: involvement of PI-3 kinase, caspase-3 and catalase. Cell Death Differ 2002;9:682-692.","DOI":"10.1038\/sj.cdd.4401019"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Ness JK, Scaduto RC Jr, Wood TL. IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4 + oligodendrocyte progenitors. Glia 2004;46:183-194.","DOI":"10.1002\/glia.10360"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, Castilla-Cortazar I, Frystyk J, Flyvbjerg A, Yoshizawa C. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. J Hepatol 2005;43:630-636.","DOI":"10.1016\/j.jhep.2005.03.025"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i17\/2731.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T22:51:13Z","timestamp":1631314273000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i17\/2731.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":46,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.2731","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}